secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0000950170-23-052392
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai receives Nasdaq bid price deficiency notice; 180-day cure period to April 3, 2024
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 6, 2023 for failing to maintain minimum $1.00 bid price for 30 consecutive business days.
- Must regain compliance by April 3, 2024 by closing at $1.00+ for at least 10 consecutive business days.
- If not cured, may seek additional 180-day period if it meets other listing standards and intends to cure via reverse stock split.
- Company will monitor bid price but cannot assure compliance will be regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023052392/0000950170-23-052392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023052392/mrai-20231006.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-052392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer